Trial
NCT05677373
Testing the Safety and Effectiveness of Combining Two Drugs, PLX2853 and Trametinib in the Treatment of Advanced Uveal Melanoma
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Alliance for Clinical Trials in Oncology
Collaborators
—
Condition
Advanced Uveal Melanoma
Intervention
BRD4 Inhibitor PLX2853
Why stopped
The drug company supporting this trial has withdrawn support, including the ability to provide study agent.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-08-18